The Feinstein Institute for Medical Research, Manhasset, New York, USA
Meggan Mackay
1Queen Elizabeth II Health Sciences Center and Dalhousie University, Rheumatology/Medicine, Halifax, Nova Scotia, Canada
Betty Diamond
8The Feinstein Institute for Medical Research, Manhasset, United States of America
Bruce Volpe
Institute of Molecule Medicine, The Feinstein Institutes for Medical Research, Manhasset, New York, USA
David Eidelberg
Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York, USA
Pina Sanelli
Radiology, Feinstein Institute for Medical Research, Manhasset, New York, USA
An Vo
The Feinstein Institutes for Medical Research, Manhasset, NY, USA
Kaitlin Carroll
SLE is a remitting and relapsing disease. Some patients even experience a clinical remission permitting them to cease using all immunosuppressive medication. Interestingly, while these individuals have no evidence of ongoing systemic inflammation, they do often exhibit manifestations of neuroinflammation
Mark Mizrachi
SLE is a remitting and relapsing disease. Some patients even experience a clinical remission permitting them to cease using all immunosuppressive medication. Interestingly, while these individuals have no evidence of ongoing systemic inflammation, they do often exhibit manifestations of neuroinflammation
